Literature DB >> 9784331

Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery.

J F Magrina1, J Gonzalez-Bosquet, A L Weaver, T A Gaffey, M J Webb, K C Podratz, J L Cornella.   

Abstract

OBJECTIVE: To evaluate the results of surgical therapy and to specifically compare radical and modified radical vulvar surgery relative to survival, recurrence, metastasis, and complications.
METHODS: A retrospective review of 225 patients with primary squamous cell cancer of the vulva was performed. Clinical, pathologic, surgical, and follow-up data were collected from the patient records. All pathology slides were reviewed with a pathologist. Radical surgery included 134 patients treated by the Basset operation. Modified radical surgery accounted for 91 patients with vulvar excision alone (65) or with lymphadenectomy (26) via separate groin incisions.
RESULTS: The 5-year recurrence rate was 14%. The overall and disease-free survival rates at 5 years were 76. 1 and 83.4%, respectively. There were no statistically significant differences between the two procedures regarding overall survival, disease-free survival, or the development of recurrence, even after adjusting for stage (P > 0.05). Patients undergoing radical vulvar surgery were more likely to develop surgical complications and sequelae than patients having modified radical surgery, even after adjusting for stage.
CONCLUSIONS: Modified radical vulvar surgery is associated with decreased complications and 5-year overall and disease-free survival and recurrence rates similar to those of radical vulvar surgery. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9784331     DOI: 10.1006/gyno.1998.5149

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

Review 2.  Pelvic floor disorders in women with gynecologic malignancies: a systematic review.

Authors:  Aparna S Ramaseshan; Jessica Felton; Dana Roque; Gautam Rao; Andrea G Shipper; Tatiana V D Sanses
Journal:  Int Urogynecol J       Date:  2017-09-19       Impact factor: 2.894

3.  Risk Factors for Postoperative Complications After Vulvar Surgery.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Iulian Brezean
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

4.  Primary mucinous adenocarcinoma of the vulva: A case report and review of the literature.

Authors:  Yanxia Sui; Junkai Zou; Nasra Batchu; Shulan Lv; Chao Sun; Jiang DU; Qing Wang; Qing Song; Qiling Li
Journal:  Mol Clin Oncol       Date:  2016-02-04

5.  Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.

Authors:  Zhihui Wang; Ana Slipicevic; Mette Førsund; Claes G Trope; Jahn M Nesland; Ruth Holm
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 6.  Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement.

Authors:  Alpaslan Kaban; Işık Kaban; Selim Afşar
Journal:  Gynecol Oncol Rep       Date:  2017-02-10

7.  Secondary healing strategy for difficult wound closure in invasive vulvar cancer: a pilot case-control study.

Authors:  Altamiro Ribeiro Dias-Jr; José Maria Soares-Jr; Maria Beatriz Sartor de Faria; Maria Luiza Noqueira Dias Genta; Jesus Paula Carvalho; Edmund C Baracat
Journal:  Clinics (Sao Paulo)       Date:  2019-09-02       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.